Iscador Qu for chronic hepatitis C: an exploratory study

Complement Ther Med. 2001 Mar;9(1):12-6. doi: 10.1054/ctim.2000.0408.

Abstract

Five patients with chronic hepatitis C were treated for one year with the herbal immunomodulatory agent Iscador (Weleda, Schwäbisch Gmünd Germany). Two patients showed 6-20 fold decreases in viral load and normalisation of liver inflammation. The treatment was well tolerated; no serious side effects were observed. The quality of life improved on average. Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Plant Extracts / therapeutic use*
  • Plant Proteins*
  • Quality of Life
  • Treatment Outcome
  • Viral Load

Substances

  • Antiviral Agents
  • Plant Extracts
  • Plant Proteins
  • viscum album peptide